📅 Tuesday, May 5, 2026 — Defensive Posture Continues
The early-May tape is delivering a consistent message: the de-risking that defined all of April has carried over into the new month with full force. $892.7M in insider volume today across 952 trades — the highest single-day trade count we've tracked in recent sessions — while the sell-to-buy ratio hit 6.1:1, the worst of the current May stretch. The breadth of Tuesday's selling is analytically notable: 952 trades with a 6.1:1 ratio means this isn't a small number of large exits skewing the data. This is broad-based institutional reduction across multiple sectors simultaneously. Congress added signal on top of it by exiting Palantir — the AI-government contractor that lawmakers had been holding as a cross-party consensus position — in a session where they placed zero buys.
Tuesday Insider Tape — May 5, 2026
Total Volume
$892.7M
Total Trades
952
Buys
38
Sells
232
Notable Buying — Regional Banking & Healthcare Services
$FGBI
$GTE
$OPCH
Notable Selling — Healthcare & Biotech
$DVA
$STKL
$TERN
1. The 6.1:1 Ratio — Reading the Breadth
📊 Sell-to-Buy Ratio — Tuesday May 5
6.1:1
232 sells · 38 buys · 952 total trades · broadest single-day participation of the May stretch
A 6.1:1 ratio on 952 trades is structurally different from a 6:1 ratio on 200 trades. When the total trade count is high and the ratio is also elevated, it confirms that the selling is distributed across many insiders at many companies — not concentrated in a single large exit skewing the aggregate. Today's tape means a wide cross-section of executives and directors, independently, chose to reduce their personal equity exposure on the same Tuesday. That convergence of independent decisions is the most analytically significant version of a high sell ratio. Monday's 4.3:1 ratio on 983 trades was notable; Tuesday's 6.1:1 on 952 deepens the pattern into a sustained signal rather than a single-day outlier.
2. The $PLTR Congressional Exit
🏛️ Congressional Activity — May 5, 2026
$766K · 3 Sells · 0 Buys
Sell-only session · Palantir + Liberty Broadband exits
$PLTR
$LBRDA
Congress has been in a consistent sell posture for most of May. Today's $766K across three trades is concentrated in Palantir ($PLTR) — the data analytics and AI platform that counts the U.S. government as its largest client — and Liberty Broadband ($LBRDA), a telecom holding company. The $PLTR exit is the headline: Palantir has been a bipartisan congressional holding because of its direct government contract exposure and its positioning as a domestic AI champion. When lawmakers begin reducing a name that is literally selling services to the government they're part of, it warrants interpretation. It may reflect concern about contract renewal risk, broader tech multiple compression, or simply profit-taking following a significant price appreciation. The absence of any congressional buy activity on Tuesday means no sector is receiving the capital being rotated out.
🔭 Ticker in Focus — Congressional Exit
$PLTR
Palantir Technologies Inc.
Palantir builds data integration and AI analytics platforms primarily for government clients — U.S. defense, intelligence agencies, and allied governments internationally — alongside a growing commercial segment. Its AIP (Artificial Intelligence Platform) product has been a central growth narrative driving the stock's premium multiple. The company sits at the exact intersection of two themes lawmakers have been actively navigating: government AI spending (long bias) and high-multiple tech valuation risk (sell bias). The congressional exit today suggests the valuation risk side of that equation has become dominant in at least some lawmakers' portfolios. Palantir's government contracts don't change with congressional trading disclosures — but internal expectations about contract renewal, budget allocation shifts, or competitive dynamics in the government AI space may.
Context on $LBRDA: Liberty Broadband is John Malone's holding company vehicle for Charter Communications exposure ($CHTR). The simultaneous exit from $LBRDA — after $CHTR was a notable insider conviction buy just last week — creates an interesting split: insiders were buying $CHTR directly while a lawmaker exits the holding company proxy for the same underlying asset. These are structurally different positions and don't necessarily contradict each other, but the divergence is worth noting.
3. Healthcare Sector — Selling & Buying Simultaneously
📉 Notable Sells — Healthcare & Biotech
Profit-Taking Across the Healthcare Spectrum
$DVA
DaVita Inc.
Kidney care and dialysis services; large-cap healthcare with recurring treatment revenue; insider trimming after a period of price appreciation — post-earnings gain locking
$TERN
Terns Pharmaceuticals
Clinical-stage biotech; obesity and metabolic disease pipeline; insider selling in a catalyst-stage company typically reflects strategic portfolio management ahead of upcoming data readouts
▲ Buy Signal — Healthcare Services Counter-Trend
$OPCH — Option Care Health · Healthcare Services Conviction Buy
$FGBI
$GTE
$OPCH
The most analytically interesting element of Tuesday's buy side is $OPCH — Option Care Health, a home and alternate-site infusion therapy provider. On a day when healthcare names are being sold ($DVA, $TERN), an insider accumulating $OPCH signals a highly specific thesis: home-based infusion services as a defensive healthcare play. Option Care operates in a segment that benefits from cost-reduction pressures in the broader healthcare system — shifting IV therapy from hospital settings to home settings is both cost-effective and clinically equivalent for many conditions. An insider buy into that business model, on a day when the sector's headline names are being reduced, is a meaningful counter-signal worth tracking. $FGBI (First Guaranty Bancshares) and $GTE (Gran Tierra Energy) complete the buy-side with regional banking and energy micro-cap context — verify float before engagement.
Methodology Note — $STKL Context
SunOpta ($STKL) — Sell Signal in Plant-Based Consumer
SunOpta produces plant-based foods and beverages, serving both retail and foodservice channels. Its appearance on today's sell list is consistent with a broader pattern of insiders exiting consumer discretionary and trend-dependent food brands as Q1 data reveals whether the plant-based category's growth trajectory has held up through a cost-conscious consumer environment. The convergence of $DVA (healthcare services), $TERN (biotech), and $STKL (plant-based consumer) on the sell side today crosses three different sub-sectors — reinforcing the "broad-based" interpretation of Tuesday's 6.1:1 ratio rather than pointing to a single sector thesis.
4. The Filing Desk — 10-Q Tide Continues
176
Tuesday · May 5 · 10-Q Continues at Peak Density
264 total · 176 10-Q · 86 8-K · 2 10-K
176 quarterly reports — 10-Q at 67% of session volume · second consecutive 170+ day
Tuesday's 176 10-Qs follow Monday's 101, continuing what has become the defining filing characteristic of early May: the Q1 earnings season that peaked in the final week of April hasn't fully normalized. Companies filing on a fiscal calendar that doesn't align perfectly with the April 15 10-Q deadline are still delivering their quarterly reports into the first week of May, keeping filing density elevated. The 86 Form 8-Ks alongside confirm that material event activity — earnings press releases, credit amendments, board disclosures — remains active as the reporting cycle completes its final days.
Week Tracker — May 5–9, 2026
Week of May 5–9, 2026
Two Sessions In — Defensive Posture Deepens
Mon 5/4
$1.9B
$RIVN + $JEF buys · $NFLX + $OKLO exits · 4.3:1
Tue 5/5
$892.7M
Congress exits $PLTR · $DVA sell · $OPCH buy · 6.1:1
Wed 5/6
—
Pending
Thu 5/7
—
Pending
Fri 5/8
—
Pending
Week Hypothesis — Two Sessions In
Monday's $1.9B and Tuesday's $892M both carried elevated sell ratios (4.3:1 and 6.1:1). The 10-Q flood continues at 101 Monday and 176 Tuesday — the Q1 earnings Truth Dump has not yet normalized. Congress has been sell-only both sessions: $JPM Monday, $PLTR and $LBRDA Tuesday. No congressional buys in the first two sessions of the week is a continuation of the defensive pivot that defined the prior Friday's 48-trade rebalancing. The hypothesis entering Wednesday: the broad-based de-risking continues until a buy-side catalyst — strong 10-Q cash flow data or a congressional re-entry — shifts the sentiment pattern.
← Previous Session
Friday May 1 — $3.2B Volume Explosion & The Congressional Defense Pivot 🛡️
→
Congress Sold $PLTR.
6.1:1 on 952 Trades. The Breadth Is the Signal.
When 232 executives independently sell on the same Tuesday, that's not noise — that's convergent conviction. InsiderPopup surfaces every Form 4 and congressional disclosure the moment it hits the SEC. The signal is in the data.
🍎 Download InsiderPopup FreeDisclaimer: This report is for informational and educational purposes only and does not constitute financial, investment, or legal advice. Insider trading data represents historical filings and is not predictive of future stock performance. We do not guarantee the accuracy or completeness of the data provided. You should conduct your own due diligence. The author and InsiderPopup are not responsible for any financial losses.